This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jan 12;354(2):189-91.

doi: 10.1056/NEJMe058295.

Optimizing ACE-inhibitor therapy for chronic kidney disease

PMID: 16407515
DOI: 10.1056/NEJMe058295

Editorial

Optimizing ACE-inhibitor therapy for chronic kidney disease

Lee A Hebert. N Engl J Med. 2006.

. 2006 Jan 12;354(2):189-91.

doi: 10.1056/NEJMe058295.

Author

PMID: 16407515
DOI: 10.1056/NEJMe058295

No abstract available

PubMed Disclaimer

Comment in

Benazepril for advanced chronic renal insufficiency.
Bloom JM. Bloom JM. N Engl J Med. 2006 Apr 6;354(14):1530-1; author reply 1530-1. doi: 10.1056/NEJMc060298. N Engl J Med. 2006. PMID: 16598052 No abstract available.

Comment on

Efficacy and safety of benazepril for advanced chronic renal insufficiency.
Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Hou FF, et al. N Engl J Med. 2006 Jan 12;354(2):131-40. doi: 10.1056/NEJMoa053107. N Engl J Med. 2006. PMID: 16407508 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal